Correction to: Nature Medicine https://doi.org/10.1038/s41591-021-01262-4, published online 11 March 2021.
In the version of this article initially published, the source of lonafarnib was not provided. This should be included as the second sentence of the Acknowledgements section, as follows: “Lonafarnib was provided by Merck through The Progeria Research Foundation’s Pre-Clinical Drug Supply Program.” The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Puttaraju, M., Jackson, M., Klein, S. et al. Author Correction: Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson–Gilford progeria syndrome. Nat Med 27, 1309 (2021). https://doi.org/10.1038/s41591-021-01415-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-021-01415-5
